- Revenue growth of 16 percent to $473.1 million;
- Net income growth of 13 percent to $65.9 million; and
- Cash flow from operations of $134.7 million.
Here are Friday's top research calls, including upgrades for IberiaBank and Actuant, and downgrades for Kimberly-Clark and Ionis Pharma.
The physician-run company is more likely to buy than be bought.